{"entity":{"type":"insider","cik":"0001858176","url":"/insider/0001858176","json_url":"/insider/0001858176.json","name":"Kemble George","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":6,"n_filings":6,"first":"2024-07-23","last":"2026-08-17","span_basis":"filed_date"},"name_variants":[{"name":"Kemble George","source":"filing","n_filings":6,"first_seen":"2024-07-23","last_seen":"2026-08-17"}],"transactions":[{"id":9255757,"accession":"0001193125-26-354018","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-354018","line_url":"/filing/0001193125-26-354018#line-1","is_derivative":false,"issuer_cik":"0001400118","issuer_name":"Sagimet Biosciences Inc.","issuer_ticker":"SGMT","issuer_name_source":null,"issuer_url":"/issuer/0001400118","owner_cik":"0001858176","owner_name":"Kemble George","owner_display_name":"Kemble George","owner_url":"/insider/0001858176","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Series A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":350987.0,"shares_display":"350,987","price_per_share":10.2328,"price_display":"10.23","price_state":"stated","total_value":3591579.7736,"total_display":"3,591,579.77","total_whole":"3,591,580","shares_owned_after":62161.0,"shares_owned_after_display":"62,161","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-14","filed_date":"2026-08-17","scope":"insider"},{"id":9255484,"accession":"0001193125-26-347407","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-347407","line_url":"/filing/0001193125-26-347407#line-1","is_derivative":false,"issuer_cik":"0001400118","issuer_name":"Sagimet Biosciences Inc.","issuer_ticker":"SGMT","issuer_name_source":null,"issuer_url":"/issuer/0001400118","owner_cik":"0001858176","owner_name":"Kemble George","owner_display_name":"Kemble George","owner_url":"/insider/0001858176","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Series A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20206.0,"shares_display":"20,206","price_per_share":9.9548,"price_display":"9.95","price_state":"stated","total_value":201146.6888,"total_display":"201,146.69","total_whole":"201,147","shares_owned_after":62161.0,"shares_owned_after_display":"62,161","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-11","filed_date":"2026-08-12","scope":"insider"},{"id":5825821,"accession":"0001193125-26-312386","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-312386","line_url":"/filing/0001193125-26-312386#line-1","is_derivative":false,"issuer_cik":"0001400118","issuer_name":"Sagimet Biosciences Inc.","issuer_ticker":"SGMT","issuer_name_source":null,"issuer_url":"/issuer/0001400118","owner_cik":"0001858176","owner_name":"Kemble George","owner_display_name":"Kemble George","owner_url":"/insider/0001858176","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Series A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18844.0,"shares_display":"18,844","price_per_share":7.4575,"price_display":"7.46","price_state":"stated","total_value":140529.13,"total_display":"140,529.13","total_whole":"140,529","shares_owned_after":62161.0,"shares_owned_after_display":"62,161","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-07-20","filed_date":"2026-07-22","scope":"insider"},{"id":4593403,"accession":"0001104659-25-115071","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-25-115071","line_url":"/filing/0001104659-25-115071#line-1","is_derivative":false,"issuer_cik":"0001400118","issuer_name":"Sagimet Biosciences Inc.","issuer_ticker":"SGMT","issuer_name_source":null,"issuer_url":"/issuer/0001400118","owner_cik":"0001858176","owner_name":"Kemble George","owner_display_name":"Kemble George","owner_url":"/insider/0001858176","role":"Director, Officer (Executive Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Chairman","security_title":"Series A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":37688.0,"shares_display":"37,688","price_per_share":7.6942,"price_display":"7.69","price_state":"stated","total_value":289979.0096,"total_display":"289,979.01","total_whole":"289,979","shares_owned_after":81005.0,"shares_owned_after_display":"81,005","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-20","filed_date":"2025-11-21","scope":"insider"},{"id":2907626,"accession":"0001104659-24-082630","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-24-082630","line_url":"/filing/0001104659-24-082630#line-1","is_derivative":false,"issuer_cik":"0001400118","issuer_name":"Sagimet Biosciences Inc.","issuer_ticker":"SGMT","issuer_name_source":null,"issuer_url":"/issuer/0001400118","owner_cik":"0001858176","owner_name":"Kemble George","owner_display_name":"Kemble George","owner_url":"/insider/0001858176","role":"Director, Officer (Executive Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Chairman","security_title":"Series A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":23625.0,"shares_display":"23,625","price_per_share":3.1674,"price_display":"3.17","price_state":"stated","total_value":74829.825,"total_display":"74,829.82","total_whole":"74,830","shares_owned_after":118693.0,"shares_owned_after_display":"118,693","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-23","filed_date":"2024-07-25","scope":"insider"},{"id":2076324,"accession":"0001104659-24-081887","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-24-081887","line_url":"/filing/0001104659-24-081887#line-1","is_derivative":false,"issuer_cik":"0001400118","issuer_name":"Sagimet Biosciences Inc.","issuer_ticker":"SGMT","issuer_name_source":null,"issuer_url":"/issuer/0001400118","owner_cik":"0001858176","owner_name":"Kemble George","owner_display_name":"Kemble George","owner_url":"/insider/0001858176","role":"Director, Officer (Executive Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Chairman","security_title":"Series A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14062.0,"shares_display":"14,062","price_per_share":3.1009,"price_display":"3.10","price_state":"stated","total_value":43604.8558,"total_display":"43,604.86","total_whole":"43,605","shares_owned_after":142318.0,"shares_owned_after_display":"142,318","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-19","filed_date":"2024-07-23","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":6,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":6,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":6},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001400118","name":"Sagimet Biosciences Inc.","url":"/issuer/0001400118","role":"Director, Officer (Executive Chairman)","n_filings":6,"first_seen":"2024-07-23","last_seen":"2026-08-17"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001858176","retrieved_at":"2026-08-25T21:15:49+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}